Dry Eyes and Menopause

Why Menopause Cause Dry Eyes?

Menopause can cause dry eyes because there are hormone receptors located on several key structures of the eye (the cornea, conjunctiva and meibomian glands) that are responsible for the integrity of the ocular surface. In pre-menopausal and post-menopausal women, hormone imbalance can result in unstable make-up of the tear film, causing chronic dry eyes–an inflammatory condition. TheraLife® can help!

TheraLife® Eye

TheraLife® Eye Enhanced has been clinically shown to stimulate tear secretion glands intracellularly (from within their cells) to allow you to produce balanced, natural tears from your own eyes.

TheraLife® Eye Enhanced is designed to restore both tear volume and tear thickness to normal levels and provide long-lasting relief for dry eyes.

TheraLife® Eye Enhanced works from the inside out so that the tear secretion is sustainable throughout the day.

TheraLife® Eye Enhanced works without washing away the valuable mucin, lipids, and protein components that lubricate the eye – unlike eye drops applied to the eye’s surface, which can actually strip the eyes of its healthy, natural substances.

TheraLife® Menopausal Support

This formula is designed for natural hormone balance. It contains black cohosh plus soy isoflavones and essential nutrients like calcium, folic acid, and B-vitamins to help balance hormonal levels and relieve symptoms of chronic dry eyes, hot flashes, night sweats, and more.

Women who are particularly concerned about synthetic hormones causing breast and ovarian cancer have used our all-natural formula as a safe and pure alternative.

Omega 3 Fish Oil

We highly recommend molecularly distilled TheraLife® Omega 3 Fish Oil to be used in addition to TheraLife® Eye Enhanced formula, because of its strong anti-inflammatory and anti-oxidant properties.

TheraLife® Fatigue

TheraLife® Fatigue formula is designed to transport more nutrients and oxygen to your body in order to reduce fatigue, provide more energy, and promote healthy sleep.

All Natural Treatment For Dry Eyes- TheraLife

Add To Cart

References

1 McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology. 1998;105:1114–9. – PubMed

References

1.

McNeil MA, Merriam SB. Menopause. Ann Intern Med. 2021 Jul;174(7):ITC97-ITC112. [PubMed]

2.

US Preventive Services Task Force. Mangione CM, Barry MJ, Nicholson WK, Cabana M, Caughey AB, Chelmow D, Coker TR, Davis EM, Donahue KE, Jaén CR, Kubik M, Li L, Ogedegbe G, Pbert L, Ruiz JM, Stevermer J, Wong JB. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: US Preventive Services Task Force Recommendation Statement. JAMA. 2022 Nov 01;328(17):1740-1746. [PubMed]

3.

Hall JE. Endocrinology of the Menopause. Endocrinol Metab Clin North Am. 2015 Sep;44(3):485-96. [PMC free article] [PubMed]

4.

Tanbo TG, Fedorcsak PZ. Can time to menopause be predicted? Acta Obstet Gynecol Scand. 2021 Nov;100(11):1961-1968. [PubMed]

5.

Talaulikar V. Menopause transition: Physiology and symptoms. Best Pract Res Clin Obstet Gynaecol. 2022 May;81:3-7. [PubMed]

6.

Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, Sherman S, Sluss PM, de Villiers TJ., STRAW+10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. Climacteric. 2012 Apr;15(2):105-14. [PMC free article] [PubMed]

7.

Crandall CJ, Mehta JM, Manson JE. Management of Menopausal Symptoms: A Review. JAMA. 2023 Feb 07;329(5):405-420. [PubMed]

8.

Burkard T, Moser M, Rauch M, Jick SS, Meier CR. Utilization pattern of hormone therapy in UK general practice between 1996 and 2015: a descriptive study. Menopause. 2019 Jul;26(7):741-749. [PubMed]

9.

Williams M, Richard-Davis G, Weickert V, Christensen L, Ward E, Schrager S. A review of African American women’s experiences in menopause. Menopause. 2022 Nov 01;29(11):1331-1337. [PubMed]

10.

Polo-Kantola P, Rantala MJ. Menopause, a curse or an opportunity? An evolutionary biological view. Acta Obstet Gynecol Scand. 2019 Jun;98(6):687-688. [PubMed]

11.

Wang X, Wang L, Xiang W. Mechanisms of ovarian aging in women: a review. J Ovarian Res. 2023 Apr 06;16(1):67. [PMC free article] [PubMed]

12.

Shifren JL. Genitourinary Syndrome of Menopause. Clin Obstet Gynecol. 2018 Sep;61(3):508-516. [PubMed]

13.

Khandelwal S, Meeta M, Tanvir T. Menopause hormone therapy, migraines, and thromboembolism. Best Pract Res Clin Obstet Gynaecol. 2022 May;81:31-44. [PubMed]

14.

Soares CN. Depression and Menopause: An Update on Current Knowledge and Clinical Management for this Critical Window. Med Clin North Am. 2019 Jul;103(4):651-667. [PubMed]

15.

de Kruif M, Spijker AT, Molendijk ML. Depression during the perimenopause: A meta-analysis. J Affect Disord. 2016 Dec;206:174-180. [PubMed]

16.

El Khoudary SR, Greendale G, Crawford SL, Avis NE, Brooks MM, Thurston RC, Karvonen-Gutierrez C, Waetjen LE, Matthews K. The menopause transition and women’s health at midlife: a progress report from the Study of Women’s Health Across the Nation (SWAN). Menopause. 2019 Oct;26(10):1213-1227. [PMC free article] [PubMed]

17.

Lee JH, Lee JE, Harsh V, Clayton AH. Pharmacotherapy for Sexual Dysfunction in Women. Curr Psychiatry Rep. 2022 Feb;24(2):99-109. [PubMed]

18.

Moolhuijsen LME, Visser JA. Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function. J Clin Endocrinol Metab. 2020 Nov 01;105(11):3361-73. [PMC free article] [PubMed]

19.

Voedisch AJ, Ariel D. Perimenopausal contraception. Curr Opin Obstet Gynecol. 2020 Dec;32(6):399-407. [PubMed]

20.

Davis SR, Baber RJ. Treating menopause – MHT and beyond. Nat Rev Endocrinol. 2022 Aug;18(8):490-502. [PubMed]

21.

Liu JH. Selective estrogen receptor modulators (SERMS): keys to understanding their function. Menopause. 2020 Oct;27(10):1171-1176. [PubMed]

22.

“The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society” Advisory Panel. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. 2023 Jun 01;30(6):573-590. [PubMed]

23.

Menown SJ, Tello JA. Neurokinin 3 Receptor Antagonists Compared With Serotonin Norepinephrine Reuptake Inhibitors for Non-Hormonal Treatment of Menopausal Hot Flushes: A Systematic Qualitative Review. Adv Ther. 2021 Oct;38(10):5025-5045. [PMC free article] [PubMed]

24.

Reid IR, Billington EO. Drug therapy for osteoporosis in older adults. Lancet. 2022 Mar 12;399(10329):1080-1092. [PubMed]

25.

Stuenkel CA, Gompel A, Davis SR, Pinkerton JV, Lumsden MA, Santen RJ. Approach to the Patient With New-Onset Secondary Amenorrhea: Is This Primary Ovarian Insufficiency? J Clin Endocrinol Metab. 2022 Feb 17;107(3):825-835. [PubMed]

26.

Singh N, Sethi A. Endometritis – Diagnosis,Treatment and its impact on fertility – A Scoping Review. JBRA Assist Reprod. 2022 Aug 04;26(3):538-546. [PMC free article] [PubMed]

27.

Ambikairajah A, Walsh E, Cherbuin N. A review of menopause nomenclature. Reprod Health. 2022 Jan 31;19(1):29. [PMC free article] [PubMed]

28.

Wu D, Cline-Smith A, Shashkova E, Perla A, Katyal A, Aurora R. T-Cell Mediated Inflammation in Postmenopausal Osteoporosis. Front Immunol. 2021;12:687551. [PMC free article] [PubMed]

29.

Stuenkel CA, Manson JE. Compounded Bioidentical Hormone Therapy: The National Academies Weigh In. JAMA Intern Med. 2021 Mar 01;181(3):370-371. [PubMed]